Gradient Investments’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10
Closed -$46 303
2024
Q2
$46 Sell
10
-1
-9% -$6 ﹤0.01% 1340
2024
Q1
$48 Sell
11
-8
-42% -$31 ﹤0.01% 1160
2023
Q4
$89 Hold
19
﹤0.01% 1743
2023
Q3
$109 Sell
19
-4
-17% -$23 ﹤0.01% 1708
2023
Q2
$124 Buy
23
+3
+15% +$18 ﹤0.01% 1670
2023
Q1
$138 Hold
20
﹤0.01% 1420
2022
Q4
$183 Sell
20
-28
-58% -$334 ﹤0.01% 1392
2022
Q3
$1K Hold
48
﹤0.01% 1187
2022
Q2
$1K Hold
48
﹤0.01% 1096
2022
Q1
$2K Buy
48
+6
+14% +$254 ﹤0.01% 1010
2021
Q4
$2K Sell
42
-1
-2% -$67 ﹤0.01% 1045
2021
Q3
$3K Hold
43
﹤0.01% 935
2021
Q2
$4K Sell
43
-20
-32% -$1.73K ﹤0.01% 898
2021
Q1
$6K Buy
63
+26
+70% +$2.91K ﹤0.01% 843
2020
Q4
$2K Hold
37
﹤0.01% 926
2020
Q3
$2K Buy
37
+2
+6% +$190 ﹤0.01% 931
2020
Q2
$4K Hold
35
﹤0.01% 757
2020
Q1
$4K Buy
35
+17
+94% +$3.04K ﹤0.01% 795
2019
Q4
$5K Hold
18
﹤0.01% 803
2019
Q3
$10K Hold
18
﹤0.01% 657
2019
Q2
$17K Buy
18
+2
+13% +$2.01K ﹤0.01% 534
2019
Q1
$17K Buy
16
+13
+433% +$11.6K ﹤0.01% 468
2018
Q4
$2K Buy
+3
New +$2.21K ﹤0.01% 805

Other funds holding ACB

Gradient Investments's ACB Position: Q3 2024 in Review

Gradient Investments sold out of Aurora Cannabis (ACB) in Q3 2024, closing a stake of 10 shares — an estimated $46 sold.

Gradient Investments first reported a position in ACB in Q4 2018 and held it in 23 quarters. The position peaked at $17K in Q2 2019. 145 funds tracked by Wall St. Rank hold ACB as of Q3 2024.

  • Gradient Investments reported no remaining Aurora Cannabis position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 10 Aurora Cannabis shares in Q3 2024, an estimated $46.
  • Gradient Investments first reported a position in Aurora Cannabis in Q4 2018 and held it in 23 quarters.
  • Gradient Investments's Aurora Cannabis position peaked at $17K in Q2 2019.
  • 145 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.